DeepMed Research

União Química Farmacêutica Nacional S/A

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: 101

Market Cap: -

Website: https://www.unionagener.com

Clinical Trials

Study With Heparin Sodium in Intravenous Administration

Phase 1

Suspended

Conditions: Heparin

Interventions: Biological: Sodium heparin UQ Intravenous drug administration
Biological: Sodium heparin FK Intravenous drug administration

First Posted Date: 2017-04-24

Last Posted Date: 2019-10-15

Lead Sponsor: União Química Farmacêutica Nacional S/A

Target Recruit Count: 24

Registration Number: NCT03125187

Locations: 🇧🇷
União Química Farmacêutica Nacional, São Paulo, Brazil

Study of Amblyomin-X in Advanced Solid Tumor

Phase 1

Suspended

Conditions: Advanced Cancer

Interventions: Biological: Amblyomin-X

First Posted Date: 2017-04-19

Last Posted Date: 2019-10-14

Lead Sponsor: União Química Farmacêutica Nacional S/A

Target Recruit Count: 24

Registration Number: NCT03120130

Locations: 🇧🇷
União Química Farmacêutica Nacional, Sao Paulo, SP, Brazil

Study With Heparin Sodium in Subcutaneous Administration

Phase 1

Suspended

Conditions: Heparin

Interventions: Biological: Sodium Heparin UQ subcutaneous drug administration
Biological: Sodium Heparin FK subcutaneous drug administration

First Posted Date: 2017-04-13

Last Posted Date: 2019-10-14

Lead Sponsor: União Química Farmacêutica Nacional S/A

Target Recruit Count: 38

Registration Number: NCT03113084

Locations: 🇧🇷
União Química Farmacêutica Nacional, São Paulo, Brazil

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy